Busey Bank - SELECT SECTOR SPDR TR ownership

SELECT SECTOR SPDR TR's ticker is XLP and the CUSIP is 81369Y308. A total of 24 filers reported holding SELECT SECTOR SPDR TR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Busey Bank ownership history of SELECT SECTOR SPDR TR
ValueSharesWeighting
Q3 2023$1,468,336
-8.1%
21,339
-0.9%
0.06%
-3.1%
Q2 2023$1,597,622
-1.1%
21,540
-0.3%
0.06%
-4.4%
Q1 2023$1,614,857
+0.0%
21,615
-0.2%
0.07%
-6.8%
Q4 2022$1,614,380
-0.9%
21,655
-11.3%
0.07%
-9.9%
Q3 2022$1,629,000
-10.1%
24,411
-2.8%
0.08%
-3.6%
Q2 2022$1,813,000
-5.8%
25,122
-0.9%
0.08%
+9.1%
Q1 2022$1,924,000
-1.6%
25,362
+0.1%
0.08%
+4.1%
Q4 2021$1,955,000
-5.7%
25,344
-15.9%
0.07%
-11.9%
Q3 2021$2,074,000
-1.9%
30,121
-0.4%
0.08%
-15.2%
Q2 2021$2,115,000
+1.2%
30,231
-1.1%
0.10%
-5.7%
Q1 2021$2,089,000
+1.3%
30,570
-0.0%
0.10%
-11.0%
Q4 2020$2,063,000
+1.9%
30,584
-3.1%
0.12%
-8.5%
Q3 2020$2,025,000
+6.8%
31,577
-2.3%
0.13%
-1.5%
Q2 2020$1,896,000
-25.6%
32,335
-30.9%
0.13%
-36.7%
Q1 2020$2,549,000
-14.3%
46,779
-1.0%
0.21%
+6.2%
Q4 2019$2,975,000
+49.3%
47,240
+45.6%
0.20%
+35.4%
Q3 2019$1,993,000
+5.8%
32,445
-0.0%
0.14%
-19.6%
Q2 2019$1,884,000
+0.5%
32,455
-2.8%
0.18%
+5.3%
Q1 2019$1,874,000
+11.6%
33,393
+1.0%
0.17%
-1.7%
Q4 2018$1,679,000
+225.4%
33,048
+231.6%
0.17%
+166.2%
Q4 2016$516,0009,9670.06%
Other shareholders
SELECT SECTOR SPDR TR shareholders Q4 2023
NameSharesValueWeighting ↓
NIPPON LIFE INSURANCE CO 7,872,387$530,993,00011.02%
Chicago Wealth Management, Inc. 163,101$11,001,00010.18%
Wechter Feldman Wealth Management, Inc. 198,264$13,373,0009.89%
J.Safra Asset Management Corp 254,732$17,182,0008.91%
AGF Investments LLC 972,305$65,582,0007.79%
Beaumont Capital Management, LLC 100,087$6,751,0006.75%
Smart Portfolios, LLC 95,058$6,411,0006.01%
FIFTH THIRD SECURITIES, INC. 182,576$12,315,0005.80%
Rothschild Capital Partners, LLC 237,709$16,033,0005.74%
Florin Court Capital LLP 165,200$11,143,0005.63%
View complete list of SELECT SECTOR SPDR TR shareholders